Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic Leukemia.
Pikman, Yana
Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic Leukemia. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Feb 2017 - 1012-1024 p. digital
Publication Type: Journal Article
1557-3265
10.1158/1078-0432.CCR-15-2869 doi
Aminopyridines--administration & dosage
Animals
Cell Line, Tumor
Cyclin-Dependent Kinase 4--antagonists & inhibitors
Dexamethasone--administration & dosage
Drug Synergism
Everolimus--administration & dosage
Humans
Mice
Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Purines--administration & dosage
T-Lymphocytes--drug effects
TOR Serine-Threonine Kinases--antagonists & inhibitors
Xenograft Model Antitumor Assays
Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic Leukemia. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Feb 2017 - 1012-1024 p. digital
Publication Type: Journal Article
1557-3265
10.1158/1078-0432.CCR-15-2869 doi
Aminopyridines--administration & dosage
Animals
Cell Line, Tumor
Cyclin-Dependent Kinase 4--antagonists & inhibitors
Dexamethasone--administration & dosage
Drug Synergism
Everolimus--administration & dosage
Humans
Mice
Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Purines--administration & dosage
T-Lymphocytes--drug effects
TOR Serine-Threonine Kinases--antagonists & inhibitors
Xenograft Model Antitumor Assays